Editas Medicine Inc
NASDAQ:EDIT

Watchlist Manager
Editas Medicine Inc Logo
Editas Medicine Inc
NASDAQ:EDIT
Watchlist
Price: 2.8 USD 2.56% Market Closed
Market Cap: 234.4m USD

Intrinsic Value

The intrinsic value of one EDIT stock under the Base Case scenario is 1.69 USD. Compared to the current market price of 2.8 USD, Editas Medicine Inc is Overvalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EDIT Intrinsic Value
1.69 USD
Overvaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Editas Medicine Inc

What is Valuation History?
Compare EDIT to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EDIT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Editas Medicine Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Editas Medicine Inc

Current Assets 182.8m
Cash & Short-Term Investments 178.5m
Receivables 588k
Other Current Assets 3.7m
Non-Current Assets 27.8m
PP&E 23.6m
Other Non-Current Assets 4.2m
Efficiency

Free Cash Flow Analysis
Editas Medicine Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Editas Medicine Inc

Revenue
38.9m USD
Operating Expenses
-199.7m USD
Operating Income
-160.8m USD
Other Expenses
-76.1m USD
Net Income
-236.9m USD
Fundamental Scores

EDIT Profitability Score
Profitability Due Diligence

Editas Medicine Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

Operating Margin is Increasing
Low 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
13/100
Profitability
Score

Editas Medicine Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

EDIT Solvency Score
Solvency Due Diligence

Editas Medicine Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
High D/E
47/100
Solvency
Score

Editas Medicine Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EDIT Price Targets Summary
Editas Medicine Inc

Wall Street analysts forecast EDIT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EDIT is 3.97 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.

Lowest
Price Target
1.01 USD
64% Downside
Average
Price Target
3.97 USD
42% Upside
Highest
Price Target
6.3 USD
125% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Editas Medicine Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EDIT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

EDIT Insider Trading
Buy and sell transactions by insiders

EDIT News

Other Videos
What is the Intrinsic Value of one EDIT stock?

The intrinsic value of one EDIT stock under the Base Case scenario is 1.69 USD.

Is EDIT stock undervalued or overvalued?

Compared to the current market price of 2.8 USD, Editas Medicine Inc is Overvalued by 40%.

Back to Top